Transfer-pricing aggregation of distinct support-service and subcontract transactions was rejected, while debt-free receivables attracted no notional ...
Customs exemptions cover photovoltaic assembly machinery and PVF backsheets, while fully declared cleared imports may avoid confiscation and penalties...
Specific tariff classification for LCD devices overrides treatment as electricity-meter parts, defeating differential duty, extended limitation, and p...
Stayed disciplinary punishment does not establish unfitness for insolvency professional registration; reconsideration must disregard mere pendency of ...
Indirect corporate control can create related-party status, excluding financial creditors from Committee of Creditors representation, participation an...
Page of 4881
Press 'Enter' after typing page number.
101 to 120 of 97618 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
Bulk drugs and active pharmaceutical ingredients qualify as "All Drugs and medicines" for concessional IGST treatment where they meet the drug description and are not within the prescribed nil-rate exclusion. The statutory drug definition includes substances intended for use as drug components; importing APIs for testing, clinical research, clinical trials, bioavailability, or bioequivalence studies does not alone change that status. The drugs-and-medicines entry applies across tariff chapters and prevails over general Chapter 28 or 29 chemical entries under the specific-over-general classification principle. Qualifying APIs attract IGST at 5%, subject to examination of the exclusion for each imported product.
Bulk drugs and active pharmaceutical ingredients qualify as "All Drugs and medicines" for concessional IGST treatment where they meet the drug description and are not within the prescribed nil-rate exclusion. The statutory drug definition includes substances intended for use as drug components; importing APIs for testing, clinical research, clinical trials, bioavailability, or bioequivalence studies does not alone change that status. The drugs-and-medicines entry applies across tariff chapters and prevails over general Chapter 28 or 29 chemical entries under the specific-over-general classification principle. Qualifying APIs attract IGST at 5%, subject to examination of the exclusion for each imported product.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4881 
